Interestingly and somewhat paradoxically, IPF patients carrying the MUC5B promoter variant rs35705950 have a better prognosis, less progressive disease, and a lower lung bacterial burden than non-carriers [10,14,15,16,17]. The gene discussed is MUC5B; the disease is idiopathic pulmonary fibrosis.